Study on hydration and potassium effects on blood pressure in young Black adults
The Effects of Water and Potassium Supplementation on Cardiovascular and Kidney Function in Young Adults
This study tests how drinking enough water and taking potassium can affect blood pressure in young Black adults aged 18-30.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 30 Years |
| Sex | All |
| Sponsor | Auburn University Academic / other |
| Locations | 1 site (Auburn, Alabama) |
| Trial ID | NCT06062017 on ClinicalTrials.gov |
What this trial studies
This study investigates the relationship between hydration, potassium intake, and cardiovascular health in Non-Hispanic Black adults aged 18-30. It aims to address the elevated risks of cardiovascular disease and chronic kidney disease in this population, particularly focusing on the impact of hydration status and potassium supplementation. Participants will receive interventions involving water and potassium supplementation to assess changes in blood pressure and hydration levels. The study also considers socioeconomic factors that may influence hydration practices among racial and ethnic minorities.
Who should consider this trial
Good fit: Ideal candidates for this study are Non-Hispanic Black adults aged 18-30 with controlled blood pressure and no metabolic or cardiovascular diseases.
Not a fit: Patients with pre-existing medical conditions that contraindicate potassium supplementation or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved hydration strategies that reduce cardiovascular and kidney disease risks in young Black adults.
How similar studies have performed: While there is limited empirical research specifically targeting hydration disparities in this demographic, studies addressing hydration and cardiovascular health have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between the ages of 18-30 years * Resting blood pressure no higher than 150/90 mmHg * BMI below 35 kg/m2 * Free of any metabolic disease (e.g., diabetes) kidney disease, pulmonary disorders (e.g., COPD), cardiovascular disease (peripheral vascular, cardiac, or cerebrovascular), no autoimmune diseases, and no history of cancer. Exclusion Criteria: * Have any precluding medical conditions (i.e. hemophilia) or medication (Pradaxa, Eliquis, etc.) that prevent participants from giving blood. * Are currently pregnant or trying to become pregnant. * take any of the following medications that are contraindicated with potassium supplementation: * Renin-angiotensin-aldosterone system (RAAS) blockers: Candesartan , Eprosartan, Irbesartan, Losartan, Olmesartan, Telmisartan * Non -steroidal anti-inflammatory medications: Aspirin, Ibuprofen, Naproxen * Non-selective beta-blockers: Pindolol, Penbutolol, Oxprenolol, Propranolol, Nadolol, Sotalol, Timolol, Tertatolol * Calcineurin inhibitors: Cyclosporine * Heparin (or other blood thinning medications)
Where this trial is running
Auburn, Alabama
- Kinesiology Building — Auburn, Alabama, United States (Recruiting)
Study contacts
- Study coordinator: Nina L Stute, M.S.
- Email: NLS0028@auburn.edu
- Phone: 9373071608
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.